Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

gilead sciences pty ltd - emtricitabine, quantity: 200 mg; tenofovir disoproxil fumarate, quantity: 300 mg; rilpivirine hydrochloride, quantity: 27.5 mg (equivalent: rilpivirine, qty 25 mg) - tablet, film coated - excipient ingredients: pregelatinised maize starch; microcrystalline cellulose; croscarmellose sodium; polysorbate 20; povidone; lactose monohydrate; magnesium stearate; titanium dioxide; hypromellose; sunset yellow fcf aluminium lake; triacetin; iron oxide red; macrogol 3350; indigo carmine aluminium lake - eviplera is indicated for the treatment of hiv infection in treatment-na?ve adult patients with plasma hiv-1 rna =< 100,000 copies/ml at the start of therapy. eviplera is also indicated in certain virologically-suppressed (hiv-1 rna <50 copies/ml) adult patients on a stable antiretroviral regimen at start of therapy in order to replace their current antiretroviral treatment regimen (see clinical trials). patients must not have a history of resistance to any of the components of eviplera (tenofovir df, emtricitabine or rilpivirine).

Irska - angleščina - HPRA (Health Products Regulatory Authority)

takeda products ireland ltd - pantoprazole sodium sesquihydrate - gastro-resistant tablet - 40 milligram(s) - proton pump inhibitors; pantoprazole

Irska - angleščina - HPRA (Health Products Regulatory Authority)

takeda products ireland ltd - pantoprazole sodium sesquihydrate - gastro-resistant tablet - 20 milligram(s) - proton pump inhibitors; pantoprazole

Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

gilead sciences (nz) - emtricitabine 200mg;  ;  ;  ;  ; rilpivirine hydrochloride 27.5mg equivalent to rilpivirine 25 mg;  ; tenofovir alafenamide fumarate 28.04mg equivalent to tenofovir alafenamide 25 mg;   - film coated tablet - 200mg/25mg/25mg - active: emtricitabine 200mg         rilpivirine hydrochloride 27.5mg equivalent to rilpivirine 25 mg   tenofovir alafenamide fumarate 28.04mg equivalent to tenofovir alafenamide 25 mg   excipient: croscarmellose sodium opadry ii grey 85f17636 lactose monohydrate magnesium stearate microcrystalline cellulose polysorbate 20 povidone - indicated as a complete regimen for the treatment of hiv-1 infection in adults and adolescents (12 years and older with a body weight at least 35 kg) with plasma hiv-1 rna less than or equal to 100,000 copies/ml at the start of therapy. the patients must not have a history of treatment failure or known mutations associated with resistance to the individual components of odefsey.

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

tri-med distributors pty ltd - urea (14c), quantity: 37 kbq - capsule, hard - excipient ingredients: fluorescein sodium; sucrose; maize starch; gelatin; silicon dioxide; sodium lauryl sulfate - pytest (urea [14c]breath test) is indicated for use in the detection of gastric urease as an aid in the diagnosis of h. pylori infection in the human stomach.